Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: The prognostic significance of serum 25-hydroxyvitamin D [25(OH)D] among older inpatients with established delirium remains uncertain. Methods: This retrospective single-center cohort included 184 adults aged ≥65 years with delirium and serum 25(OH)D measured within seven days of admission during the period of 2020–2025. Outcomes were all-cause mortality and hospital length of stay. Vitamin D was modeled continuously in Cox regression; baseline comparisons were exploratory. Results: During follow-up, 47 patients (25.5%) died: 31/120 (25.8%) with 25(OH)D concentrations < 30 ng/mL and 16/64 (25.0%) with concentrations ≥30 ng/mL (log-rank p = 0.731). Median follow-up was 30.4 months (reverse Kaplan–Meier; 95% CI 28.1–34.0). The proportional-hazards-corrected multivariable Cox estimate per 10-ng/mL increase was HR 1.09 (95% CI 0.91–1.30; p = 0.354); the minimally adjusted age–sex–CCI estimate was HR 1.07 (95% CI 0.91–1.26; p = 0.407). Adjusted median length of stay was also not associated with serum 25(OH)D (difference of −0.81 days per 10-ng/mL increase, 95% CI −2.18 to 0.56; p = 0.250). Results were consistent across ward, landmark, spline, ridge-penalized, and additional sensitivity analyses. Other covariate and baseline associations were exploratory. Conclusions: Serum 25(OH)D was not significantly associated with mortality or length of stay in this selected retrospective single-center cohort of hospitalized older adults with documented delirium and timely 25(OH)D measurement. The findings were consistent across multiple sensitivity analyses, although the confidence intervals do not establish equivalence or exclude smaller associations. This study cannot evaluate delirium incidence or the effects of vitamin D supplementation. Substantial cohort exclusions, the moderate sample size, limited mortality events, and unavailable functional and frailty measures restrict generalizability. The null findings are informative within this selected population but should not be generalized beyond it without prospective multicenter validation.
Source: Diagnostics
Authors: Dana Kagansky(Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing), Hadar Vaknin Laufer(Data curation, Investigation), Maya Wurman(Data curation, Investigation), Dror Nattel-Wright(Data curation, Investigation), Erica Pinco, Michal Bitan(Formal analysis, Methodology, Writing – review & editing), Daniel Trotzky(Writing – review & editing), Miya Sharfman(Writing – review & editing), Yochai Levy(Supervision, Writing – review & editing), Nadya Kagansky(Conceptualization, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Topic: Vitamin D Research Studies
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: delirium, 25-hydroxyvitamin D, vitamin D, older adults, hospitalized patients, all-cause mortality, length of hospital stay, prognostic factors, frailty, comorbidities, vitamin D supplementation, delirium prevention and treatment, mortality risk stratification, hospital readmission, quality of life, quality of care
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236195915
